Your browser doesn't support javascript.
loading
Nanoparticles of a Pyrazolo-Pyridazine Derivative as Potential EGFR and CDK-2 Inhibitors: Design, Structure Determination, Anticancer Evaluation and In Silico Studies.
Hashem, Heba E; Amr, Abd El-Galil E; Almehizia, Abdulrahman A; Naglah, Ahmed M; Kariuki, Benson M; Eassa, Heba A; Nossier, Eman S.
Afiliação
  • Hashem HE; Department of Chemistry, Faculty of Women, Ain Shams University, Cairo 11757, Egypt.
  • Amr AEE; Applied Organic Chemistry Department, National Research Center, Cairo 12622, Egypt.
  • Almehizia AA; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
  • Naglah AM; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
  • Kariuki BM; School of Chemistry, Cardiff University, Main Building, Park Place, Cardiff CF10 3AT, UK.
  • Eassa HA; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11754, Egypt.
  • Nossier ES; Department of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of Saint Joseph, West Hartford, CT 06117, USA.
Molecules ; 28(21)2023 Oct 25.
Article em En | MEDLINE | ID: mdl-37959672
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridazinas / Nanopartículas / Antineoplásicos Limite: Humans Idioma: En Revista: Molecules Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridazinas / Nanopartículas / Antineoplásicos Limite: Humans Idioma: En Revista: Molecules Ano de publicação: 2023 Tipo de documento: Article